Table S1 - Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接:
官方服务:
资源简介:
Summary of regimens supported by the literature. (DOCX)
创建时间:
2014-06-26




